Project Grant R43NS127710
- This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $994,138 to Modendo Inc., a for-profit company located in Boulder, CO, to develop and validate a prototype ultrathin endomicroscope instrument for high-resolution, minimally invasive optical imaging of the brain in animal neuroscience research. The key innovation is achieving a cross-sectional area more than 10 times smaller than...
- Modendo Inc. received a $256,000 Small Business Innovation Research Phase I Project Grant from the National Science Foundation to develop an ultrathin endomicroscope. The grant was awarded under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to advance science and engineering research leading to breakthrough technologies. Specifically, the funding will support Modendo's development of a new class of minimally invasive endoscope probes with diameters as small as 100...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,295,800 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a novel optical endoscope that does not require mechanical rotation to perform 360-degree in vivo imaging. The project aims to design and fabricate a metasurface that can...
- The National Science Foundation (NSF) awarded a Project Grant under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to Lensguide Imaging Technology Inc. for $275,000 to develop a nano-optical imaging microendoscope for in vivo imaging. The project aims to create a hair-sized, 100 μm diameter microendoscope that can image at depths greater than 3 mm in live animals with subcellular resolution, overcoming limitations of current optical imaging technologies. This...
- This NSF Engineering Program award of $605,320 to North Carolina State University (NC State) supports the development of a flexible, FMRI-compatible neural probe with multi-modal sensing and modulation capabilities. The novel probe is designed to advance understanding of neural circuit dynamics and enable closed-loop neuromodulation for treating neurological disorders. Key product elements include: Flexible, multi-shank neural probe fabricated using polymeric materials to enable deep brain...
- This federal Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $416,925 to Objective Biotechnology, Inc. to develop and evaluate a miniature, high-performance microscope system for imaging brain activity in freely behaving mice. The award period runs from September 15, 2025 to August 31, 2027. The key objectives are to engineer the "Mini-MScope" device with a highly sensitive imaging sensor, evaluate its...
- This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $549,958 to the University of California Irvine (UC Irvine) to develop a meta-optical fiber endoscope (MOFE) device. The MOFE aims to significantly reduce the size of endoscopic imaging components, enabling less invasive medical procedures and expanding the range of biomedical applications. Key objectives include integrating optical metasurfaces...
- The National Science Foundation awarded $256,000 to Optave Diagnostics LLC through the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a prototype endoscopic probe for molecular imaging and diagnosis of cancerous prostate pathologies. The 12-month project grant will support the creation of a medical device using photoacoustic imaging and acoustic lens technology to aid in the detection and diagnosis of prostate cancer. The proposed endoscopic probe offers an alternative...
- The University of Minnesota was awarded a $3,972,414 Project Grant from the National Institute of Neurological Disorders and Stroke within the Department of Health and Human Services to develop an electro-optical multiphoton microscope. The microscope will leverage advances in electro-optical beam deflection to enable random-access multiphoton interrogation of neurons and synapses with sub-microsecond access times. This will allow neuroscientists to collect the simultaneous recordings needed...
- The National Science Foundation awarded Pensievision, Inc. $255,947 under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an endoscopic 3D imaging system for evaluating cancers and disorders of the esophagus and pharynx. The Small Business Innovation Research Phase I project will combine liquid lens technology, artificial intelligence software, and astronomical imaging techniques to generate three-dimensional images of early-stage esophageal and throat tumors....
MULTI-PROBE MINIMALLY INVASIVE ENDOMICROSCOPE - PROJECT SUMMARY THIS PROJECT SEEKS TO DEVELOP A MULTI-PROBE ULTRATHIN ENDOMICROSCOPE TO ENABLE HIGH-RESOLUTION IMAGING AND PHOTO-STIMULATION AT MULTIPLE SITES WITHIN CURRENTLY INACCESSIBLE REGIONS OF THE BRAIN. THE INSTRUMENT WILL BE AMENABLE TO SCIENTIFIC STUDIES IN MODEL ANIMALS AND A STEPPING STONE FOR FUTURE MEDICAL INSTRUMENTATION TARGETED AT DIAGNOSIS AND DISEASE TREATMENT IN HUMANS. THE COMPANY ADDRESSES THE CRITICAL NEED IN THE SCIENTIFIC AND MEDICAL FIELDS FOR ENDOSCOPES THAT ARE MINIMALLY INVASIVE, WITH A CROSS SECTION IN THE ORDER OF 100MM. THE PROPOSED SYSTEM PROTOTYPE WILL BE DIGITALLY PROGRAMMED, CONTAIN NO MOVING PARTS, AND SIMULTANEOUSLY ADDRESS MULTIPLE PROBES THAT PENETRATE TISSUE WITH NEGLIGIBLE DAMAGE. THE TARGET APPLICATION IS DEEP BRAIN IMAGING AND PHOTO-STIMULATION SIMULTANEOUSLY IN MULTIPLE REGIONS OF THE BRAIN. THE SYSTEM WILL ENABLE IMAGING DIFFICULT-TO-REACH BRAIN AREAS, SUCH AS THE BRAIN STEM OR THE OLFACTORY BULB, WITH NEGLIGIBLE TRAUMA TO THE ANIMAL. THE POSSIBILITY OF INSERTING MULTIPLE IMAGING PROBES TO CORRELATE STIMULATION AND ACTIVITY IN DIFFERENT REGIONS OF THE BRAIN COULD PROVIDE NEW UNDERSTANDING OF THE CONNECTOME AND HELP OBSERVE DIFFERENCES BETWEEN HEALTHY AND DISEASED BRAINS. CURRENT ENDOSCOPIC SOLUTIONS ARE APPROPRIATE FOR INSERTION IN LARGE CAVITIES BUT THEY PRODUCE EXCESSIVE DAMAGE IN APPLICATIONS SUCH AS DEEP BRAIN IMAGING. THIS PROJECT WILL CREATE A MINIMALLY-INVASIVE, ROBUST, FLEXIBLE, AND COMPACT PROTOTYPE FOR MULTI-PROBE ENDOMICROSCOPY. THE KEY INNOVATION IS IN ACHIEVING THE FUNDAMENTALLY THINNEST MECHANISM TO TRANSMIT A HIGH INFORMATION CONTENT IMAGE IN REAL TIME AND IN PARALLELIZING IT TO MULTIPLE BRAIN SITES. THE INDIVIDUAL PROBES HAVE A CROSS-AREA 10 TIMES SMALLER THAN THE THINNEST EXISTING ENDOSCOPES. FURTHER, EACH OF THE PROBES WILL BE ABLE TO DELIVER MULTIPLE FUNCTIONS: 3D IMAGING WITH MICROMETER RESOLUTION, FLUORESCENCE AND REFLECTION IMAGING, AS WELL AS LASER PATTERN GENERATION FOR PHOTO-STIMULATION AND ABLATION. THE IMAGING APPROACH IMPLEMENTS WAVEFRONT SHAPING IN VARIOUS MULTIMODE FIBER PROBES SIMULTANEOUSLY, USING ADVANCED MACHINE LEARNING AND SIGNAL PROCESSING METHODS, TO GENERATE ARBITRARY DIGITALLY-REPROGRAMMABLE LIGHT PATTERNS AND 3D IMAGES. THE SYSTEM USES A SPATIAL LIGHT MODULATOR TO FIRST CALIBRATE EACH FIBER AND THEN SCAN LIGHT AT HIGH SPEED, COMPENSATING FOR THE INHERENT MODAL DISPERSION AND INTERMODAL COUPLING. THE DEMONSTRATION OF THE FIRST IN-VIVO IMAGING AND OPTOGENETICS EXPERIMENTS THROUGH A MULTIMODE FIBER, SHOWING POPULATIONS OF NEURONS INDIVIDUALLY IMAGED AT DEPTH, WITH SUBCELLULAR RESOLUTION, AND WITH MINIMAL TISSUE DAMAGE, OPENS EXCITING OPPORTUNITIES FOR EXPANSION AND DEVELOPMENT INTO MULLTI-PROBE MULTI-MODALITY SYSTEMS. THE COMPANY'S INITIAL FOCUS IS ON DE-RISKING AND VALIDATING THE USE OF MULTIMODE FIBER PROBES IN ANIMAL FUNCTIONAL NEURO-IMAGING. THE LONG-TERM VISION IS TO TRANSLATE THE TECHNOLOGY TOWARDS MEDICAL APPLICATIONS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $121.3k | 9/18/23 | ||
| Not listed | $238.8k | 9/18/23 | ||
| Not listed | $450.0k | 9/24/22 | ||
| Not listed | $450.0k | 9/24/22 |